1. Home
  2. ANAB vs GIC Comparison

ANAB vs GIC Comparison

Compare ANAB & GIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$62.39

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

GIC

Global Industrial Company

HOLD

Current Price

$33.18

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
GIC
Founded
2005
1949
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
ANAB
GIC
Price
$62.39
$33.18
Analyst Decision
Buy
Analyst Count
12
0
Target Price
$71.67
N/A
AVG Volume (30 Days)
570.6K
132.9K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
3.44%
EPS Growth
91.02
17.09
EPS
N/A
0.42
Revenue
$234,603,000.00
$1,379,100,000.00
Revenue This Year
N/A
$5.72
Revenue Next Year
$52.14
$4.60
P/E Ratio
N/A
$79.07
Revenue Growth
157.01
4.80
52 Week Low
$17.11
$26.40
52 Week High
$73.30
$38.53

Technical Indicators

Market Signals
Indicator
ANAB
GIC
Relative Strength Index (RSI) 56.57 58.37
Support Level $52.32 $32.35
Resistance Level $67.69 $34.39
Average True Range (ATR) 3.27 0.96
MACD 0.87 0.00
Stochastic Oscillator 54.78 54.30

Price Performance

Historical Comparison
ANAB
GIC

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About GIC Global Industrial Company

Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw material.

Share on Social Networks: